Background--Atherosclerotic abdominal aortic aneurysm (AAA) is a progressive, gradual aortic rupture that results in death in the absence of surgical intervention. Key factors that regulate initiation and progression of AAA are unknown, making targeted interventions difficult. MicroRNAs play a fundamental role in atherosclerosis, and atherosclerotic coronary artery disease is characterized by tissue-and plasma-specific microRNA signatures. However, little is known about microRNAs involved in AAA pathology. This study examined tissue and plasma microRNAs specifically associated with AAA.
A therosclerosis is a global concern and generates an array of lethal pathologies in the elderly. Abdominal aortic aneurysm (AAA) is a common atherosclerosis-related disease that eventually leads to aortic rupture and death if not treated by graft replacement surgery or covered stent implantation, which are the established armamentarium against this pathology. AAA is a progressive disease characterized by aortic wall atherosclerosis, in which vascular smooth muscle cells (VSMCs) and infiltrating monocytes/ macrophages are activated to release a variety of factors, including matrix metalloproteinases, angiotensin II, tumor necrosis factor (TNF)-a, interleukin-1b, interleukin-6, and interferon-c, consequently generating a chronic inflammatory state. However, key factors that regulate initiation or progression of these processes, and thus potential therapeutic targets, are poorly studied.
MicroRNAs (miRNAs), which are small noncoding RNAs that posttranscriptionally regulate gene expression, 1 play a major role in several biological and pathological processes, including cellular activities, 2-5 atherosclerosis, 6 and cancer. 7 Initiation and progression of some atherosclerosis-related cardiovascular diseases are regulated at least partially by local miRNA signatures, which therefore could be therapeutic targets; however, expression patterns and biological roles of miRNA in AAA pathogenesis have not been elucidated. In addition, the circulating plasma miRNA signature might be correlated with the local miRNA expression signature of a specific pathology and thus can be used clinically as a biomarker. 8 Although it recently was suggested that some specific miRNA signatures might be present in the plasma of patients with coronary artery atherosclerotic disease, little is known about AAA-specific plasma miRNA signatures.
In the present study, we hypothesized that atherosclerosisrelated miRNAs are upregulated or downregulated in AAA tissue and in plasma of patients with AAA, as compared to the normal population. Therefore, we comprehensively analyzed miRNA expression in human AAA tissue by using oligonucleotide microarray and real-time quantitative polymerase chain reaction (PCR) to identify candidate miRNAs, and we further confirmed their roles in AAA pathogenesis. Moreover, we examined relationships between blood circulatory miRNA expression and pathological changes of the aorta.
Methods
This study was approved by the institutional ethics committee (reference No. 09277). All members of the study cohort gave written informed consent before entering the study. All evaluations were carried out in a blinded manner. The authors had full access to the data and take full responsibility for the integrity of the data. All authors have read and agreed to the manuscript as written.
Cohort Background and Characteristics and Sample Collection
We collected full-thickness aortic wall samples from the anterior wall of the infrarenal AAA (aneurysmal area) of 13 patients undergoing elective open AAA repair. We also sampled ascending aorta without visible atherosclerotic changes (normal aorta) as age-and sex-matched controls from 7 patients undergoing aortic valve replacement surgery (Table 1) . Preoperative characteristics, including hypertension, diabetes mellitus, and "on-statin" medication status, were not different between the 2 groups. Aortic wall samples were processed promptly for RNA and histological analysis. In addition, we collected blood samples from 23 patients with AAA; 12 healthy volunteers without atherosclerotic disease or inflammatory disorders, as a control group; and 17 patients with coronary artery disease (CAD), as a disease control group (Table 2) . Age, hypertension, and "on-statin" status were not similar among the 3 groups. Patients with impaired ejection fraction, heart failure, unstable CAD, or acute myocardial injury were excluded. General exclusion criteria were a known history of leucopenia, thrombocytopenia, or severe hepatic or renal dysfunction, as well as evidence for inflammatory or malignant disease. The plasma was separated promptly and stored at À80°C until use.
RNA Isolation and Purification From Tissue and Blood Samples
Aortic wall samples were submerged in RNAlater (Qiagen, Hilden, Germany) at 4°C and were homogenized by Tissue Lyser II homogenizer (Qiagen). We extracted total RNA from tissue and plasma samples by using the mirVana miRNA and mirVana PARIS RNA isolation kits, respectively (Ambion, Austin, TX). Concentration and purity of extracted RNA were 
Histology
Aortic wall samples were fixed promptly in 10% formalinphosphate buffer and embedded in paraffin. Five-micrometer sections were stained with hematoxylin and eosin or were immunohistolabeled with a mouse anti-CD68 monoclonal antibody (Dako, Glostrup, Denmark, 1:100 dilution) and visualized by the labeled streptavidin-biotin method (Dako). Histological slides were assessed by optical microscopy (BIOREVO BZ-9000, Keyence Corp, Osaka, Japan).
Statistical Analysis
Continuous variables are summarized as mean ± standard deviation and categorical variables as frequencies and proportions. All the continuous variables were checked for normality via the Kolmogorov-Smirnov test and graphically. Normally distributed and nonnormally distributed variables were compared between 2 groups with the Student t test and the Mann-Whitney U test, respectively. Comparisons among 3 groups were made with the 1-way analysis of variance, followed by the post hoc pairwise Student t test, or the Kruskal-Wallis test, followed by the post hoc pairwise Wilcoxon-Mann-Whitney U test, as appropriate. Categorical variables were compared with the Fisher exact test. Correlations were tested with the use of the Spearman correlation coefficient. The multiple regression model also was used to adjust for the following baseline patient characteristics simultaneously: age, hypertension, and statin use. (There are statistically significant imbalances in these baseline characteristics among the 3 groups for plasma samples.) Nonnormally distributed dependent variables in the multiple regression analysis were natural log-transformed to satisfy normality of the used models, as appropriate. Multiple comparisons among the 3 groups in the multiple regression analysis were made with the use of the Tukey contrast described by Westfall 9 and as implemented by Hothorn et al. 10 The multiplicity in pairwise comparisons was corrected by the Bonferroni procedure. All probability values are 2 sided, and values of P<0.05 were considered to indicate statistical significance. Statistical analysis was performed in SPSS 15.0 (SPSS Inc, Chicago, IL) and the R program.
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Results

Differential Expression of miRNAs in Human AAA Tissue
We comprehensively analyzed the miRNA expression profile in AAA wall tissue by using an miRNA microarray and compared it with the profile in normal aortic wall tissue. The heatmap diagram showed a marked difference in several miRNA expression levels (Figure 1 ). Among 384 miRNAs analyzed, 77 were upregulated >2-fold in AAA tissue, and none were downregulated compared to normal aortic tissue ( Table 3) . The miRNAs that were reproducibly and reliably altered in the microarray analysis (P<0.05 and >2-fold change) were considered to be differentially expressed genes and were further assessed quantitatively by real-time PCR. Endothelial miRNAs, such as miR-126, miR-20a, miR-27a, miR-92a, miR-221, miR-222, members of the let-7 family, and miR-21, were significantly upregulated in AAA tissue compared with normal aortic tissue, whereas expression of vascular smooth muscleenriched miRNAs, such as miR-143 and miR-145, were not significantly different (Figure 2 ). Cardiac-and skeletal muscle-expressed miRNAs, such as miR-1, miR-133a, and miR-499-3p, also showed no significant difference. Monocyte/macrophage-related miRNAs, such as miR-155, miR146a, miR-223, and miR-124a, were significantly upregulated in AAA tissue compared with normal aortic wall tissue, as was the fibrosis-related miRNA, miR-29b (Figure 2 ).
Inflammatory Changes in AAA Tissue
Inflammation-related miRNAs (miR-155, miR-146a, miR-223, and miR-124a) were upregulated in AAA tissue compared with normal aortic wall tissue; therefore, we further examined the severity of inflammation in AAA tissues.
Hematoxylin-and-eosin staining of AAA wall tissue showed typical features of established atherosclerosis, such as fibrotic changes of the media or inflammatory cell infiltration, in contrast to staining of normal aortic wall tissue, which showed 3 layers (adventia, media, and intima) and had a heterogeneous mixture of smooth muscle, endothelial cells, fibroblast cells, and a complex extracellular matrix ( Figure 3A and 3B). We assessed macrophage presence and distribution in AAA tissues by immunohistolabeling for CD68. CD68-positive cells were abundantly present in the intima of AAA tissues compared to normal aortic wall tissue, in which CD68-positive cells were rarely present ( Figure 3C and 3D) .
Correlation of Local miRNA Expression With Inflammatory Changes
The expression of specific miRNAs is altered by extracellular signals, such as MCP-1, cytokines (TNF-a, TGF-b), and fibroblast metalloprotease. [12] [13] [14] [15] [16] miR-124a and miR-146a are key MCP-1 miRNAs, and miR-126, miR-146a, and miR-223 are associated with several inflammatory diseases. 12, 15, 17 We assessed expression of factors/molecules related to inflammation or fibrosis in AAA and normal aortic wall tissues by using real-time PCR for the following: MCP-1; TNF-a; TGF-b; matrix metalloproteinase-1, -2, -3, and -9; and tissue inhibitor of metalloproteinase-1, -2, -3, and -9. In addition, we statistically evaluated the correlation between expression of these factors and miRNAs. The results showed negative correlations between MCP-1 and miR-124, miR-146a, and miR-223; between TNF-a and miR-126 and miR-223; and between TGF-b and miR-146a (Figure 4 ).
Plasma miRNA Signature in Patients With AAA
Subsequently, we analyzed preoperatively collected plasma of patients with AAA (n=23), patients with CAD (n=17), and healthy volunteers (n=12) by real-time PCR for the miRNAs that were upregulated in AAA tissues (miR-15a, -15b, -124a, -126, -223, -21, -29b, -155, and -146a). To determine an endogenous plasma control, we selected miR-16 and snRNA U6 RNAs as candidates. miR-16 was more stably expressed than U6 in our sample plasma and was therefore used as a housekeeping miRNA in this study.
The healthy volunteers consistently expressed the miRNAs noted above in the plasma. In contrast, endothelial miRNAs (miR-126), inflammation-related miRNAs (miR-124a, -146a, -155, and -223), fibrosis-related miRNA (miR-29b), and apoptosis-related miRNA (miR-15a, -15b) were significantly significantly downregulated in the plasma of patients with AAA compared to the plasma from patients with CAD ( Figure 5 ). However, there were statistically significant imblances in age, hypertension, and "on-statin" status among the 3 plasma sample groups (Table 2) . Therefore, the multiple regression model also was used to adjust for these characteristics. As a result, in the adjusted analyses, expression of miRNAs such as fibrosis-related miRNA (miR-29b) and inflammation-related miRNAs (miR-124a, -155, and -223) was also significantly reduced in plasma of patients with AAA compared to healthy controls and patients with CAD ( Figure 5 ). Moreover, in each of the adjusted analyses, the adjusted age, hypertension, and "onstatin" status become not significant.
Discussion
We demonstrated that the miRNA expression profile in human AAA wall tissue was quite different from that in normal aortic wall tissue, including endothelial (let-7f and miR-20a, -21, -27, -92a, -126, -221, and -222), inflammatory (miR-124a, -146a, -155, and -223), and fibrosis-related miRNAs (miR-29b). In particular, we found that vessel wall-related and inflammatory cell-derived miRNAs were significantly upregulated in aortic aneurysm wall tissue. These miRNA expression changes were correlated closely with inflammatory cytokines, including MCP-1, TNF-a, and TGF-b, which are responsible for AAA pathophysiology. Moreover, we analyzed the circulating miRNA expression profile of patients with AAA. Interestingly, miRNAs that were upregulated in human AAA wall tissue were significantly downregulated in plasma from patients with AAA.
The characteristic pathological features of AAA are atherosclerotic change, chronic aortic wall inflammation, elastic media destruction, macrophage infiltration, neovascularization, and VSMC apoptosis. 17 An inflammatory response to vascular injury can lead to atherosclerotic plaque formation, instigated by rapid proliferation, growth, and apoptosis of VSMCs, as well as aberrant VSMC plasticity that has been observed in a variety of pathological vascular disorders, including atherosclerosis. Increasing evidence indicates that numerous miRNAs, which could be responsible for the pathogenesis and pathophysiology of vascular injury and disease, show marked alterations in their expression. 5 In our study, endothelial miRNAs including miR-21, miR-221, and miR-222 were significantly upregulated in AAA tissue compared to control tissue. These miRNAs are enriched in endothelial cells and regulate neointima lesion formation. Downregulation of aberrantly expressed miR-21 decreases neointima formation in rat carotid artery after angioplasty, which suggests that miR-21 regulates expression of some RNA expression responsible for neointimal lesion formation. 5 At the molecular level, miR-21 controls VSMC proliferation and apoptosis via phosphatase, tensin homology deleted from chromosome 10 (PTEN), 5 and programmed cell death 4 (PDCD4). 18 PTEN is expressed in endothelial cells and VSMCs,
where it modulates cell survival and apoptosis via its target molecules, phosphoinositide-3 kinases and Akt. 19 PDCD4
attenuated by upregulated miR-21 induces VSMC apoptosis through upregulation of activator protein-1. [20] [21] [22] [23] In fact, a study showed that miR-21 was a key modulator of apoptosis of vascular wall smooth muscle cells during development of AAA in established murine models. 24 We can speculate that upregulated miR-21 in AAA tissue induces VSMC apoptosis via downregulation of its 3 target genes and that measurement of miR-21 could become diagnostic in clinical settings. A recent study showed that p27 (Kip1) and p57 (Kip2), negative regulators for VSMC proliferation, are 2 gene targets of miR-221 and miR-222 in rat carotid artery in vivo. 25 Expression of miR-221 and miR-222 is upregulated and localized in the injured vascular walls of VSMCs in rat carotid arteries after angioplasty. Moreover, knockdown of miR-221 and miR-222 in rat carotid arteries suppressed VSMC proliferation in vivo and neointimal lesion formation after angioplasty. 26 Thus, upregulation of tissue miR-21, -221, and -222 in the present study suggests that they are important factors for regulating VSMC apoptosis and proliferation and are involved in the pathogenesis of atherosclerotic diseases such as AAA, whereas the downregulation of these miRNAs in the circulation could predict pathological changes of the aortic wall.
There is also evidence that some miRNAs control vascular inflammation. miR-126 inhibits expression of vascular cell adhesion molecule-1, which mediates leukocyte adherence to endothelial cells. 26 A decrease in endothelial cell miR-126 increases vascular cell adhesion molecule-1 expression and enhances leukocyte adherence. In addition, the myeloid-specific miR-223 regulates progenitor cell proliferation as well as granulocyte differentiation and activation during inflammation, 12 and miR-146 is induced in macrophages by several microbial components and proinflammatory cytokines in a nuclear factor-jB-dependent manner. 2 Thus, miR-126, miR-223, and miR-146 could be responsible for inflammatory responses via different pathways in various vascular diseases, including atherosclerosis and aortic aneurysm. Chronic inflammation of the aortic wall plays an important role in AAA pathogenesis, and activated macrophages are the primary cells secreting various proteases that lead to disruption of the orderly lamellar structure of the aortic media. Our study revealed that these inflammation-related and monocyte/macrophage-regulated miRNAs were significantly upregulated in AAA tissues and were significantly correlated with MCP-1, TNF-a, and TGF-b in diseased aortic walls, which suggests that these miRNAs indirectly predict the severity of aortic wall inflammation. Although these miRNAs are promising biomarkers of AAA or other atherosclerotic disease, inflammatory changes occur in other inflammatory diseases, such as rheumatism. These alterations in miRNA expression likely represent pathological rather than etiologic characteristics of AAA, and AAA should be carefully diagnosed in combination with the expression of other miRNAs.
In this study, miRNAs that were upregulated in AAA tissue were downregulated in the circulation. Tanaka et al 27 have
reported that plasma miR-92a values in non-Hodgkin's lymphoma were extremely low compared with healthy subjects, although miR-92a is overexpressed in malignant lymphoma cells. They speculated that miRNAs are packaged inside exsomes that are secreted from cells and that it might be possible that cancer cells specifically take in the exosome that contains miR-92a, with the result being that miR-92a decreases in the blood. 27, 28 As an alternative explanation, cancer cells might specifically digest miR-92a in the plasma directly or indirectly. Moreover, circulating levels of vascular and inflammation-associated miRNAs are significantly downregulated in patients with CAD, 29 although tissue miRNA expression was not evaluated. There is speculation that miRNAs are delivered to atherosclerotic lesions by apoptotic bodies and that the reduction of circulating miRNAs in patients with CAD is caused by an uptake of circulating miRNAs into atherosclerotic lesions. 30 In our study, we demonstrated that expression of many miRNAs was significantly upregulated in AAA wall tissue, which supports the above speculation, but further study is needed. Figure 5 . Circulating miRNAs in patients with AAA vs disease controls vs healthy volunteers. Expression of selected miRNAs in EDTA-plasma obtained from patients with AAA (n=23), disease controls (DC; n=17), and healthy controls (HC; n=12), as determined by TaqMan PCR. Post hoc pairwise Wilcoxon-Mann-Whitney U test was used after the Kruskal-Wallis test, and multiple regression analysis with natural log-transformation of the expression data was performed, because all the expression data were considered to be nonnormally distributed. Statistically significant differences: *P<0.05, multiple comparison with the Bonferroni correction based on the post hoc pairwise Wilcoxon-Mann-Whitney U test); +P<0.05, multiple comparison with the Bonferroni correction based on multiple regression analysis with adjustment for age, hypertension, and statin). Vertical bars represent standard error. AAA indicates abdominal aortic aneurysm; miRNA, microRNA; and PCR, polymerase chain reaction.
A limitation of the present study is that although our miRNA array analysis detected numerous miRNAs with significantly changed expression in AAA wall tissue, we did not confirm function. Further experimental studies are needed to explore unknown functions of other miRNAs that were expressed in AAA tissue and plasma. Additionally, we used thoracic aorta as control tissue. Although the developmental origin of thoracic aorta is the same as abdominal aorta, and miRNA expression was predicted to be similar, miRNA expression could vary slightly.
In summary, this study provides a first view of miRNA expression profiles in human AAA tissue and supports the idea that miRNAs play an important role in pathological processes of vascular diseases such as AAA. Moreover, circulating levels of vascular and inflammation-associated miRNAs that were upregulated in AAA tissue were significantly downregulated in plasma of patients with AAA. Analyses of miRNA expression could provide useful new biomarkers to diagnose AAA and some clues to develop miRNA-targeted AAA therapies.
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